Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod ; volume:16 ; number:1 ; day:8 ; month:8 ; year:2016 ; pages:1-11 ; date:12.2016
BMC neurology ; 16, Heft 1 (8.8.2016), 1-11, 12.2016
- Creator
- Contributor
-
Kern, Raimar
Cornelissen, Christian
SpringerLink (Online service)
- DOI
-
10.1186/s12883-016-0648-6
- URN
-
urn:nbn:de:1111-201609057008
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ziemssen, Tjalf
- Kern, Raimar
- Cornelissen, Christian
- SpringerLink (Online service)
Other Objects (12)
The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
Fingolimod in children with Rett syndrome: the FINGORETT study
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence
Fingolimod modulates microglial activation to augment markers of remyelination
Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study
Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study
Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease
Contributions to the noise analysis of switched capacitor circuits
Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study)
A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study
The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
Fingolimod in children with Rett syndrome: the FINGORETT study
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence
Fingolimod modulates microglial activation to augment markers of remyelination
Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study
Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study
Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease
Contributions to the noise analysis of switched capacitor circuits
Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study)
A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study
The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
Fingolimod in children with Rett syndrome: the FINGORETT study
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
Part three: a randomized study to assess biomarker changes in cigarette smokers switched to Vuse Solo or Abstinence
Fingolimod modulates microglial activation to augment markers of remyelination
Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study
Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study
Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease
Contributions to the noise analysis of switched capacitor circuits
Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study)